ES2162927T3 - Formulacion para la aplicacion por inhalacion. - Google Patents
Formulacion para la aplicacion por inhalacion.Info
- Publication number
- ES2162927T3 ES2162927T3 ES95924299T ES95924299T ES2162927T3 ES 2162927 T3 ES2162927 T3 ES 2162927T3 ES 95924299 T ES95924299 T ES 95924299T ES 95924299 T ES95924299 T ES 95924299T ES 2162927 T3 ES2162927 T3 ES 2162927T3
- Authority
- ES
- Spain
- Prior art keywords
- mum
- inhalation
- formulation
- application
- particle size
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Abstract
SE DESCRIBE UNA FORMULACION FARMACEUTICA PARA UTILIZARSE EN INHALADORES EN POLVO. SE COMPONE DE UN CUERPO BASE Y ADHERIDO A EL UN MEDICAMENTO O UNA MEZCLA DE MEDICAMENTOS. LA FORMULACION ES FACILMENTE REDISPERSABLE, DE TAL MANERA QUE SE DESCOMPONE RAPIDAMENTE EN PARTICULAS CAPACES DE PASAR A LOS PULMONES. LA FORMULACION SE EMPLEA PARA LA OBTENCION DE MEDICAMENTOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4425255A DE4425255A1 (de) | 1994-07-16 | 1994-07-16 | Formulierung zur inhalativen Applikation |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2162927T3 true ES2162927T3 (es) | 2002-01-16 |
Family
ID=6523404
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95924299T Expired - Lifetime ES2162927T3 (es) | 1994-07-16 | 1995-06-21 | Formulacion para la aplicacion por inhalacion. |
Country Status (32)
Country | Link |
---|---|
US (1) | US6284287B1 (es) |
EP (1) | EP0771189B1 (es) |
JP (1) | JP3011770B2 (es) |
KR (1) | KR970704422A (es) |
CN (1) | CN1234344C (es) |
AT (1) | ATE204160T1 (es) |
AU (1) | AU703924B2 (es) |
BR (1) | BR9508287A (es) |
CA (1) | CA2195065C (es) |
CZ (1) | CZ290921B6 (es) |
DE (2) | DE4425255A1 (es) |
DK (1) | DK0771189T3 (es) |
ES (1) | ES2162927T3 (es) |
FI (1) | FI118790B (es) |
HR (1) | HRP950403B1 (es) |
HU (1) | HU223069B1 (es) |
IL (1) | IL114596A (es) |
IS (1) | IS1889B (es) |
MX (1) | MX9700034A (es) |
MY (1) | MY115688A (es) |
NO (1) | NO315894B1 (es) |
NZ (1) | NZ289117A (es) |
PL (1) | PL186153B1 (es) |
PT (1) | PT771189E (es) |
RU (1) | RU2140260C1 (es) |
SK (1) | SK282764B6 (es) |
TR (1) | TR199500856A2 (es) |
TW (1) | TW475904B (es) |
UA (1) | UA29507C2 (es) |
WO (1) | WO1996002231A1 (es) |
YU (1) | YU49279B (es) |
ZA (1) | ZA955892B (es) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9700133D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
EP0876814A1 (en) * | 1997-05-07 | 1998-11-11 | "PHARLYSE", Société Anonyme | Dry powder inhaler excipient, process for its preparation and pharmaceutical compositions containing it |
IT1309592B1 (it) * | 1999-03-05 | 2002-01-24 | Chiesi Farma Spa | Particelle veicolo modificate da utilizzarsi nella preparazione diformulazioni farmaceutiche sotto forma di polimeri per inalazione e |
ITMI991582A1 (it) | 1999-07-16 | 2001-01-16 | Chiesi Farma Spa | Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala |
CA2387212A1 (en) | 1999-10-12 | 2001-04-19 | Kaken Pharmaceutical Co., Ltd. | Dry powder inhalation and a method for the preparation thereof |
GB0008660D0 (en) * | 2000-04-07 | 2000-05-31 | Arakis Ltd | The treatment of respiratory diseases |
PE20011227A1 (es) | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros |
GB0009468D0 (en) | 2000-04-17 | 2000-06-07 | Vectura Ltd | Improvements in or relating to formulations for use in inhaler devices |
ATE364381T1 (de) * | 2000-04-17 | 2007-07-15 | Vectura Ltd | Formulierungen zur verwendung in inhalationsvorrichtungen |
GB0009469D0 (en) | 2000-04-17 | 2000-06-07 | Vectura Ltd | Improvements in or relating to formalities for use in inhaler devices |
TR200402367T4 (tr) | 2000-10-12 | 2004-12-21 | Boehringer Ingelheim Pharma Gmbh& Co.Kg | Yeni tiotropyum içeren inhalasyon tozları |
UA75375C2 (en) * | 2000-10-12 | 2006-04-17 | Boehringer Ingelheim Pharma | Method for producing powdery preparations for inhaling |
US7776315B2 (en) * | 2000-10-31 | 2010-08-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on anticholinergics and additional active ingredients |
US20020151541A1 (en) * | 2000-10-31 | 2002-10-17 | Michel Pairet | Pharmaceutical compositions containing tiotropium salts and antihistamines and their use |
US20100310477A1 (en) * | 2000-11-28 | 2010-12-09 | Boehringer Ingelheim Pharma Gmbh & Co. Kg. | Pharmaceutical compositions based on anticholingerics and additional active ingredients |
US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
US7766013B2 (en) | 2001-06-05 | 2010-08-03 | Alexza Pharmaceuticals, Inc. | Aerosol generating method and device |
US7645442B2 (en) | 2001-05-24 | 2010-01-12 | Alexza Pharmaceuticals, Inc. | Rapid-heating drug delivery article and method of use |
US7458374B2 (en) | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
US6681768B2 (en) | 2001-06-22 | 2004-01-27 | Sofotec Gmbh & Co. Kg | Powder formulation disintegrating system and method for dry powder inhalers |
DE10141376A1 (de) * | 2001-08-23 | 2003-03-13 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung von Inhalationspulvern |
DE10141377A1 (de) * | 2001-08-23 | 2003-03-13 | Boehringer Ingelheim Pharma | Aufstreuverfahren zur Herstellung von Pulverformulierungen |
US6702997B2 (en) | 2001-10-26 | 2004-03-09 | Dey, L.P. | Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma |
US20030191151A1 (en) * | 2001-10-26 | 2003-10-09 | Imtiaz Chaudry | Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
JP2003221335A (ja) | 2001-10-26 | 2003-08-05 | Dey Lp | 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法 |
US20030140920A1 (en) * | 2001-10-26 | 2003-07-31 | Dey L.P. | Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma |
US20030203930A1 (en) * | 2001-10-26 | 2003-10-30 | Imtiaz Chaudry | Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
US7754242B2 (en) * | 2002-03-20 | 2010-07-13 | Alkermes, Inc. | Inhalable sustained therapeutic formulations |
AU2003280102B2 (en) * | 2002-06-28 | 2007-01-25 | Alkermes, Inc. | Inhalable epinephrine |
ATE520405T1 (de) * | 2002-08-21 | 2011-09-15 | Norton Healthcare Ltd | Inhalationszusammensetzung |
GB0219511D0 (en) * | 2002-08-21 | 2002-10-02 | Norton Healthcare Ltd | Method of preparing dry powder inhalation compositions |
US20050158248A1 (en) * | 2002-08-21 | 2005-07-21 | Xian-Ming Zeng | Method of preparing dry powder inhalation compositions |
US20040105818A1 (en) | 2002-11-26 | 2004-06-03 | Alexza Molecular Delivery Corporation | Diuretic aerosols and methods of making and using them |
US7913688B2 (en) | 2002-11-27 | 2011-03-29 | Alexza Pharmaceuticals, Inc. | Inhalation device for producing a drug aerosol |
DE10255387A1 (de) * | 2002-11-28 | 2004-06-09 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Tiotropium-haltige Pulverformulierung für die Inhalation |
US7763280B2 (en) | 2002-11-28 | 2010-07-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Tiotropium containing powder formulation for inhalation |
WO2004104491A2 (en) | 2003-05-21 | 2004-12-02 | Alexza Pharmaceuticals, Inc. | Percussively ignited or electrically ignited self-contained heating unit and drug-supply unit employing same |
GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
US20070020298A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid |
US20070020299A1 (en) | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
JP2007533387A (ja) | 2004-04-21 | 2007-11-22 | イノベータ バイオメド リミテッド | 吸入器 |
GB0409197D0 (en) | 2004-04-24 | 2004-05-26 | Innovata Biomed Ltd | Device |
US7540286B2 (en) | 2004-06-03 | 2009-06-02 | Alexza Pharmaceuticals, Inc. | Multiple dose condensation aerosol devices and methods of forming condensation aerosols |
GB0613161D0 (en) * | 2006-06-30 | 2006-08-09 | Novartis Ag | Organic Compounds |
EP1925295A1 (de) * | 2006-11-22 | 2008-05-28 | Boehringer Ingelheim Pharma GmbH & Co. KG | Stabile Pulverformulierung enthaltend ein Anticholinergikum |
EP1944018A1 (en) * | 2007-01-10 | 2008-07-16 | CHIESI FARMACEUTICI S.p.A. | Micronised particles of low-dosage strength active agents for powder formulations for inhalation |
KR20090129998A (ko) | 2007-02-11 | 2009-12-17 | 맵 파마슈티컬스, 인코포레이티드 | 부작용 프로파일을 최소화하면서 편두통의 빠른 완화를 가능하게 하는 dhe의 치료적 투여 방법 |
US20080216828A1 (en) | 2007-03-09 | 2008-09-11 | Alexza Pharmaceuticals, Inc. | Heating unit for use in a drug delivery device |
WO2010011813A1 (en) * | 2008-07-23 | 2010-01-28 | Alkermes, Inc. | Complex of trospium and pharmaceutical compositions thereof |
JP5705112B2 (ja) * | 2008-07-30 | 2015-04-22 | エスティーシー.ユーエヌエム | ドライパウダー吸入エアロゾル用の大径キャリア粒子を含む製剤 |
EP3842058B1 (en) | 2011-12-13 | 2023-08-23 | Pieris Pharmaceuticals GmbH | Methods for preventing or treating certain disorders by inhibiting binding of il-4 and/or il-13 to their respective receptors |
WO2013128283A2 (en) * | 2012-02-28 | 2013-09-06 | Iceutica Holdings Inc. Bvi | Inhalable pharmaceutical compositions |
ES2776208T3 (es) | 2015-12-03 | 2020-07-29 | Tiefenbacher Alfred E Gmbh & Co Kg | Procedimiento de mezcladura de polvo seco |
MX2022003427A (es) | 2019-09-24 | 2022-04-18 | Chiesi Farm Spa | Particulas portadoras novedosas para formulaciones de polvo seco para inhalacion. |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3860618A (en) | 1967-08-08 | 1975-01-14 | Philip Saxton Hartley | Chromone |
US3957965A (en) | 1967-08-08 | 1976-05-18 | Fisons Limited | Sodium chromoglycate inhalation medicament |
GB1242211A (en) * | 1967-08-08 | 1971-08-11 | Fisons Pharmaceuticals Ltd | Pharmaceutical composition |
GB1381872A (en) * | 1971-06-22 | 1975-01-29 | Fisons Ltd | Pharmaceutical compositions for inhalation |
GB1410588A (en) * | 1971-08-10 | 1975-10-22 | Fisons Ltd | Composition |
DE2535258C2 (de) * | 1974-08-10 | 1993-06-03 | Fisons Plc, Ipswich, Suffolk | Inhalierbares Medikament in Pelletform |
GB1520247A (en) | 1974-08-10 | 1978-08-02 | Fisons Ltd | Pelletised medicament formulations |
GB1520248A (en) | 1975-07-24 | 1978-08-02 | Fisons Ltd | Sodium cromoglycate containing medicament |
US4161516A (en) | 1975-07-25 | 1979-07-17 | Fisons Limited | Composition for treating airway disease |
IL51233A (en) | 1975-07-28 | 1980-07-31 | Fisons Ltd | Pharmaceutical compositions in the form of soft pellets or granules |
IL57956A (en) | 1975-07-28 | 1980-07-31 | Fisons Ltd | Disodium cromoglycate in pellet or granule form having a low loose bulk density |
AU522792B2 (en) | 1977-07-19 | 1982-06-24 | Fisons Plc | Pressure pack formulation |
GB1571629A (en) * | 1977-11-30 | 1980-07-16 | Fisons Ltd | Pharmaceutical compositions containing beclomethasone dipropionate |
GB2077100B (en) * | 1980-04-30 | 1985-04-24 | Fisons Ltd | Pharmaceutical compositions containing cromoglycates |
IT1204826B (it) | 1986-03-04 | 1989-03-10 | Chiesi Farma Spa | Composizioni farmaceutiche per inalazione |
GB9001635D0 (en) * | 1990-01-24 | 1990-03-21 | Ganderton David | Aerosol carriers |
US5376386A (en) | 1990-01-24 | 1994-12-27 | British Technology Group Limited | Aerosol carriers |
AU7239191A (en) * | 1990-01-25 | 1991-08-21 | University Of Colorado Foundation, Inc., The | Method for preventing immune suppression in trauma patients |
GB9027968D0 (en) * | 1990-12-22 | 1991-02-13 | Fisons Plc | Method of treatment |
DE4140689B4 (de) | 1991-12-10 | 2007-11-22 | Boehringer Ingelheim Kg | Inhalationspulver und Verfahren zu ihrer Herstellung |
US5658549A (en) * | 1991-12-12 | 1997-08-19 | Glaxo Group Limited | Aerosol formulations containing propellant 134a and fluticasone propionate |
TW244350B (es) | 1991-12-14 | 1995-04-01 | Hoechst Ag | |
DE69332240T2 (de) | 1992-06-12 | 2003-04-10 | Teijin Ltd | Ultrafeines pulver zur inhalation und dessen herstellung |
IS1736B (is) | 1993-10-01 | 1999-12-30 | Astra Ab | Aðferð og tæki sem stuðla að aukinni samloðun agna |
GB9322014D0 (en) | 1993-10-26 | 1993-12-15 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
-
1994
- 1994-07-16 DE DE4425255A patent/DE4425255A1/de not_active Withdrawn
-
1995
- 1995-06-21 UA UA97020661A patent/UA29507C2/uk unknown
- 1995-06-21 RU RU97102349A patent/RU2140260C1/ru not_active IP Right Cessation
- 1995-06-21 PT PT95924299T patent/PT771189E/pt unknown
- 1995-06-21 NZ NZ289117A patent/NZ289117A/en not_active IP Right Cessation
- 1995-06-21 WO PCT/EP1995/002392 patent/WO1996002231A1/de active IP Right Grant
- 1995-06-21 CN CNB95194066XA patent/CN1234344C/zh not_active Expired - Fee Related
- 1995-06-21 CZ CZ1997126A patent/CZ290921B6/cs not_active IP Right Cessation
- 1995-06-21 HU HU9700131A patent/HU223069B1/hu not_active IP Right Cessation
- 1995-06-21 MX MX9700034A patent/MX9700034A/es not_active IP Right Cessation
- 1995-06-21 ES ES95924299T patent/ES2162927T3/es not_active Expired - Lifetime
- 1995-06-21 SK SK56-97A patent/SK282764B6/sk not_active IP Right Cessation
- 1995-06-21 KR KR1019970700209A patent/KR970704422A/ko not_active Application Discontinuation
- 1995-06-21 AT AT95924299T patent/ATE204160T1/de not_active IP Right Cessation
- 1995-06-21 CA CA002195065A patent/CA2195065C/en not_active Expired - Fee Related
- 1995-06-21 AU AU28862/95A patent/AU703924B2/en not_active Ceased
- 1995-06-21 JP JP8504624A patent/JP3011770B2/ja not_active Expired - Fee Related
- 1995-06-21 EP EP95924299A patent/EP0771189B1/de not_active Expired - Lifetime
- 1995-06-21 DK DK95924299T patent/DK0771189T3/da active
- 1995-06-21 PL PL95318649A patent/PL186153B1/pl not_active IP Right Cessation
- 1995-06-21 BR BR9508287A patent/BR9508287A/pt active Search and Examination
- 1995-06-21 US US08/765,928 patent/US6284287B1/en not_active Expired - Fee Related
- 1995-06-21 DE DE59509518T patent/DE59509518D1/de not_active Expired - Lifetime
- 1995-06-30 TW TW084106804A patent/TW475904B/zh active
- 1995-07-11 YU YU46095A patent/YU49279B/sh unknown
- 1995-07-14 HR HR950403A patent/HRP950403B1/xx not_active IP Right Cessation
- 1995-07-14 ZA ZA955892A patent/ZA955892B/xx unknown
- 1995-07-14 TR TR95/00856A patent/TR199500856A2/xx unknown
- 1995-07-14 IL IL11459695A patent/IL114596A/xx not_active IP Right Cessation
- 1995-07-17 MY MYPI95002021A patent/MY115688A/en unknown
-
1996
- 1996-12-13 IS IS4396A patent/IS1889B/is unknown
-
1997
- 1997-01-08 NO NO19970068A patent/NO315894B1/no not_active IP Right Cessation
- 1997-01-15 FI FI970164A patent/FI118790B/fi active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2162927T3 (es) | Formulacion para la aplicacion por inhalacion. | |
BRPI0015567B8 (pt) | composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica | |
BR9909192A (pt) | Preparações galênicas de meloxicam para administração oral | |
ES2170069T3 (es) | 1-alfa-hidroxiprevitamina d para administracion oral. | |
BR0115382A (pt) | Formulações para liberação controlada de hidrocodona, método de produzir analgesia efetiva, processo de preparação de uma forma farmacêutica de um sólido oral de liberação controlada, liberação controlada da forma farmacêutica oral e uso da forma farmacêutica | |
CA2335065A1 (en) | Pharmaceutical formulations for aerosols with two or more active substances | |
ES2152966T3 (es) | Formas de dosificado farmaceuticas de desleido rapido y procedimiento para su preparacion. | |
CL2009001682A1 (es) | Composición farmacéutica espontáneamente dispersable para administración oral que comprende n-benzoil-estaurosporina; método para incrementar los niveles de biodisponibilidad. (divisional de la solocitud 333-00). | |
AR004700A1 (es) | 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento | |
ES8307496A1 (es) | Procedimiento para la obtencion de una preparacion galenica antagonista al calcio. | |
GR890100833A (en) | Process for the preparation of a compound with gastric inhibitopy effect | |
AR035006A1 (es) | Derivado de naftiridin-dibenzo[a,d]ciclohepteno-10-acetico, composicion farmaceutica, y el uso de dicho derivado para la fabricacion de un medicamento. | |
DK0742716T3 (da) | Farmaceutisk sammensætning til systemisk transdermal indgivelse med det aktive middel morphin-6-glucuronid | |
BR0010449A (pt) | 14beta-h-esteróis, composições farmacêuticas que compreendem os mesmos e uso destes derivados para a preparação de medicamentos reguladores da meiose | |
ES2064104T3 (es) | Procedimiento de preparacion de composiciones farmaceuticas del tipo de liberacion prolongada destinadas a la administracion por via oral. | |
PE20011042A1 (es) | Uso de glutamina para la prevencion de diarrea de inicio tardio inducida por irinotecan | |
SE8304818D0 (sv) | A medicine having anti-ulcer, spasmolytic and locally anesthetic effect | |
ES2135424T3 (es) | Composicion oral a base de ibuprofeno. | |
IT1262929B (it) | Impiego terapeutico del monosialodiesosil ganglioside gm3 e derivati come agenti anti-angiogenici |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 771189 Country of ref document: ES |